Does the media favor ITGR or PRCT?

In the previous week, PROCEPT BioRobotics had 21 more articles in the media than Integer. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 32 mentions for Integer. Integer's average media sentiment score of 0.72 beat PROCEPT BioRobotics' score of 0.02 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 17 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 4 Very Positive mention(s) 1 Positive mention(s) 44 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media favor PRCT or HAE?

In the previous week, PROCEPT BioRobotics had 23 more articles in the media than Haemonetics. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 30 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.71 beat PROCEPT BioRobotics' score of 0.02 indicating that Haemonetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 4 Very Positive mention(s) 1 Positive mention(s) 44 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Haemonetics 7 Very Positive mention(s) 4 Positive mention(s) 13 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IRTC or PRCT?

In the previous week, PROCEPT BioRobotics had 27 more articles in the media than iRhythm Technologies. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 26 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.61 beat PROCEPT BioRobotics' score of 0.02 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 9 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive PROCEPT BioRobotics 4 Very Positive mention(s) 1 Positive mention(s) 44 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to PRCT or ESTA?

In the previous week, PROCEPT BioRobotics had 35 more articles in the media than Establishment Labs. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 18 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.18 beat PROCEPT BioRobotics' score of 0.02 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 4 Very Positive mention(s) 1 Positive mention(s) 44 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Establishment Labs 3 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to PRCT or TMDX?

In the previous week, PROCEPT BioRobotics had 24 more articles in the media than TransMedics Group. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 29 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.03 beat PROCEPT BioRobotics' score of 0.02 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 4 Very Positive mention(s) 1 Positive mention(s) 44 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral TransMedics Group 6 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 6 Negative mention(s) 0 Very Negative mention(s) Neutral

PROCEPT BioRobotics (PRCT) Competitors

$20.41 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$20.32 -0.09 (-0.47%)

As of 08/7/2026 07:34 PM Eastern

Compare

PRCT vs. ITGR, HAE, IRTC, ESTA, and TMDX

Should you buy PROCEPT BioRobotics stock or one of its competitors? MarketBeat compares PROCEPT BioRobotics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with PROCEPT BioRobotics include Integer (ITGR), Haemonetics (HAE), iRhythm Technologies (IRTC), Establishment Labs (ESTA), and TransMedics Group (TMDX). These companies are all part of the "healthcare equipment" industry.

How does PROCEPT BioRobotics compare to Integer?

Integer (NYSE:ITGR) and PROCEPT BioRobotics (NASDAQ:PRCT) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

Integer has a net margin of 6.97% compared to PROCEPT BioRobotics' net margin of -32.53%. Integer's return on equity of 12.79% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

99.3% of Integer shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Integer has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, PROCEPT BioRobotics has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

Integer currently has a consensus price target of $109.86, indicating a potential downside of 12.16%. PROCEPT BioRobotics has a consensus price target of $28.00, indicating a potential upside of 37.19%. Given PROCEPT BioRobotics' stronger consensus rating and higher probable upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19

Integer has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.29	$102.81M	$3.66	34.17
PROCEPT BioRobotics	$308.05M	3.77	-$95.57M	-$1.94	N/A

In the previous week, PROCEPT BioRobotics had 21 more articles in the media than Integer. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 32 mentions for Integer. Integer's average media sentiment score of 0.72 beat PROCEPT BioRobotics' score of 0.02 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	17 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
PROCEPT BioRobotics	4 Very Positive mention(s)	1 Positive mention(s)	44 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Integer beats PROCEPT BioRobotics on 9 of the 17 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to Haemonetics?

PROCEPT BioRobotics (NASDAQ:PRCT) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Haemonetics has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	3.77	-$95.57M	-$1.94	N/A
Haemonetics	$1.35B	2.94	$97.31M	$2.04	42.89

PROCEPT BioRobotics presently has a consensus target price of $28.00, suggesting a potential upside of 37.19%. Haemonetics has a consensus target price of $90.89, suggesting a potential upside of 3.87%. Given PROCEPT BioRobotics' higher probable upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 4.0% of PROCEPT BioRobotics shares are owned by company insiders. Comparatively, 2.1% of Haemonetics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, PROCEPT BioRobotics had 23 more articles in the media than Haemonetics. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 30 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.71 beat PROCEPT BioRobotics' score of 0.02 indicating that Haemonetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	4 Very Positive mention(s)	1 Positive mention(s)	44 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Haemonetics	7 Very Positive mention(s)	4 Positive mention(s)	13 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

PROCEPT BioRobotics has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

Haemonetics has a net margin of 7.12% compared to PROCEPT BioRobotics' net margin of -32.53%. Haemonetics' return on equity of 27.55% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%
Haemonetics	7.12%	27.55%	9.65%

Summary

Haemonetics beats PROCEPT BioRobotics on 11 of the 16 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and PROCEPT BioRobotics (NASDAQ:PRCT) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

iRhythm Technologies presently has a consensus target price of $179.36, indicating a potential upside of 40.30%. PROCEPT BioRobotics has a consensus target price of $28.00, indicating a potential upside of 37.19%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe iRhythm Technologies is more favorable than PROCEPT BioRobotics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19

iRhythm Technologies has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market. Comparatively, PROCEPT BioRobotics has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market.

iRhythm Technologies has a net margin of -1.69% compared to PROCEPT BioRobotics' net margin of -32.53%. iRhythm Technologies' return on equity of 10.11% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

iRhythm Technologies has higher revenue and earnings than PROCEPT BioRobotics. iRhythm Technologies is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.64	-$44.55M	-$0.43	N/A
PROCEPT BioRobotics	$308.05M	3.77	-$95.57M	-$1.94	N/A

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, PROCEPT BioRobotics had 27 more articles in the media than iRhythm Technologies. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 26 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.61 beat PROCEPT BioRobotics' score of 0.02 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	9 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
PROCEPT BioRobotics	4 Very Positive mention(s)	1 Positive mention(s)	44 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

iRhythm Technologies beats PROCEPT BioRobotics on 13 of the 17 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to Establishment Labs?

PROCEPT BioRobotics (NASDAQ:PRCT) and Establishment Labs (NASDAQ:ESTA) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment.

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 4.0% of PROCEPT BioRobotics shares are owned by company insiders. Comparatively, 10.0% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Establishment Labs has a net margin of -15.82% compared to PROCEPT BioRobotics' net margin of -32.53%. PROCEPT BioRobotics' return on equity of -30.62% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%
Establishment Labs	-15.82%	-205.79%	-10.75%

PROCEPT BioRobotics presently has a consensus price target of $28.00, indicating a potential upside of 37.19%. Establishment Labs has a consensus price target of $100.25, indicating a potential upside of 29.49%. Given PROCEPT BioRobotics' higher possible upside, equities analysts plainly believe PROCEPT BioRobotics is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

PROCEPT BioRobotics has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market.

Establishment Labs has lower revenue, but higher earnings than PROCEPT BioRobotics. Establishment Labs is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	3.77	-$95.57M	-$1.94	N/A
Establishment Labs	$211.08M	10.79	-$51.06M	-$1.31	N/A

In the previous week, PROCEPT BioRobotics had 35 more articles in the media than Establishment Labs. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 18 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.18 beat PROCEPT BioRobotics' score of 0.02 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	4 Very Positive mention(s)	1 Positive mention(s)	44 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Establishment Labs	3 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Establishment Labs beats PROCEPT BioRobotics on 10 of the 17 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to TransMedics Group?

PROCEPT BioRobotics (NASDAQ:PRCT) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

PROCEPT BioRobotics presently has a consensus price target of $28.00, indicating a potential upside of 37.19%. TransMedics Group has a consensus price target of $124.18, indicating a potential upside of 48.03%. Given TransMedics Group's stronger consensus rating and higher probable upside, analysts plainly believe TransMedics Group is more favorable than PROCEPT BioRobotics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

PROCEPT BioRobotics has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

TransMedics Group has a net margin of 22.69% compared to PROCEPT BioRobotics' net margin of -32.53%. TransMedics Group's return on equity of 15.88% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%
TransMedics Group	22.69%	15.88%	5.95%

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 4.0% of PROCEPT BioRobotics shares are owned by company insiders. Comparatively, 6.9% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, PROCEPT BioRobotics had 24 more articles in the media than TransMedics Group. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 29 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.03 beat PROCEPT BioRobotics' score of 0.02 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	4 Very Positive mention(s)	1 Positive mention(s)	44 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
TransMedics Group	6 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	6 Negative mention(s)	0 Very Negative mention(s)	Neutral

TransMedics Group has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	3.77	-$95.57M	-$1.94	N/A
TransMedics Group	$605.49M	4.79	$190.29M	$3.89	21.57

Summary

TransMedics Group beats PROCEPT BioRobotics on 15 of the 17 factors compared between the two stocks.

Get PROCEPT BioRobotics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRCT vs. The Competition

Export

Metric	PROCEPT BioRobotics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.16B	$5.76B	$7.00B	$12.99B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	-10.52	24.26	270.59	25.05
Price / Sales	3.77	68.36	599.41	84.35
Price / Cash	N/A	33.55	28.89	37.44
Price / Book	3.12	6.11	11.21	6.43
Net Income	-$95.57M	$149.01M	$3.45B	$348.10M
7 Day Performance	11.04%	2.54%	3.41%	2.68%
1 Month Performance	-2.30%	0.78%	-0.71%	-0.83%
1 Year Performance	-46.86%	4.93%	77.31%	23.97%

PROCEPT BioRobotics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRCT PROCEPT BioRobotics	2.7636 of 5 stars	$20.41 flat	$28.00 +37.2%	-46.9%	$1.16B	$308.05M	N/A	430	Trending News Earnings Report
ITGR Integer	2.3794 of 5 stars	$124.45 +2.7%	$103.71 -16.7%	+17.5%	$4.12B	$1.85B	31.03	11,000	Earnings Report High Trading Volume
HAE Haemonetics	3.1194 of 5 stars	$86.79 +1.5%	$78.89 -9.1%	+62.4%	$3.89B	$1.33B	42.96	3,009	Trending News Earnings Report Analyst Forecast
IRTC iRhythm Technologies	4.2061 of 5 stars	$124.66 +6.4%	$184.71 +48.2%	-19.3%	$3.85B	$747.14M	N/A	2,400	Trending News Earnings Report Analyst Forecast Gap Up
ESTA Establishment Labs	3.2803 of 5 stars	$92.80 +0.3%	$93.75 +1.0%	+122.5%	$2.72B	$211.08M	N/A	1,004	Trending News Earnings Report Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRCT) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PROCEPT BioRobotics (PRCT) Competitors

PRCT vs. ITGR, HAE, IRTC, ESTA, and TMDX

How does PROCEPT BioRobotics compare to Integer?

Summary

How does PROCEPT BioRobotics compare to Haemonetics?

Summary

How does PROCEPT BioRobotics compare to iRhythm Technologies?

Summary

How does PROCEPT BioRobotics compare to Establishment Labs?

Summary

How does PROCEPT BioRobotics compare to TransMedics Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT vs. The Competition

PROCEPT BioRobotics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PROCEPT BioRobotics (PRCT) Competitors

PRCT vs. ITGR, HAE, IRTC, ESTA, and TMDX

How does PROCEPT BioRobotics compare to Integer?

Is ITGR or PRCT more profitable?

Do insiders & institutionals believe in ITGR or PRCT?

Which has more volatility and risk, ITGR or PRCT?

Do analysts recommend ITGR or PRCT?

Which has stronger valuation and earnings, ITGR or PRCT?

Does the media favor ITGR or PRCT?

Summary

How does PROCEPT BioRobotics compare to Haemonetics?

Which has preferable valuation and earnings, PRCT or HAE?

Do analysts prefer PRCT or HAE?

Do institutionals & insiders hold more shares of PRCT or HAE?

Does the media favor PRCT or HAE?

Which has more volatility & risk, PRCT or HAE?

Is PRCT or HAE more profitable?

Summary

How does PROCEPT BioRobotics compare to iRhythm Technologies?

Do analysts prefer IRTC or PRCT?

Which has more risk & volatility, IRTC or PRCT?

Is IRTC or PRCT more profitable?

Which has better earnings & valuation, IRTC or PRCT?

Do institutionals & insiders have more ownership in IRTC or PRCT?

Does the media favor IRTC or PRCT?

Summary

How does PROCEPT BioRobotics compare to Establishment Labs?

Do insiders and institutionals believe in PRCT or ESTA?

Is PRCT or ESTA more profitable?

Do analysts recommend PRCT or ESTA?

Which has more volatility & risk, PRCT or ESTA?

Which has better valuation and earnings, PRCT or ESTA?

Does the media refer more to PRCT or ESTA?

Summary

How does PROCEPT BioRobotics compare to TransMedics Group?

Do analysts prefer PRCT or TMDX?

Which has more volatility & risk, PRCT or TMDX?

Is PRCT or TMDX more profitable?

Do institutionals & insiders have more ownership in PRCT or TMDX?

Does the media refer more to PRCT or TMDX?

Which has better valuation and earnings, PRCT or TMDX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT vs. The Competition

PROCEPT BioRobotics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools